Insiders Of Avid Bioservices Reap Rewards After Their Investment Jumps Another US$385k
Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference
Sector Update: Health Care
Avid Bioservices Shares Jump as RBC Boosts Price Target After Bookings Beat
Avid Bioservices Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Adjusted EPS Results. Also, RBC Capital Maintained an Outperform Rating on the Stock and Raised Its Price Target From $8 to $12.
Avid Bioservices Up Over 20%, on Pace for Largest Percent Increase Since March 2023 -- Data Talk
